Walker Marlan D's Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Apr 14, 2023
- Accession no.
- 0001209191-23-024388
- Filed
- Apr 14, 2023
- Trade date
- Apr 12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $4.27K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001209191-23-027361 (May 4, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walker Marlan DCIK 0001820187 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | MOption exerciseAcquired | +3,030 | $0.00 | $0 | 8,999 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseAcquired | +1,010 | $0.00 | $0 | 10,009 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseAcquired | +1,734 | $0.00 | $0 | 11,743 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseAcquired | +1,734 | $0.00 | $0 | 13,477 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −1,170 | $3.65 | −$4,270.5 | 12,307 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −3,030 | $0.00 | $0 | 0 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −1,010 | $0.00 | $0 | 0 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −1,734 | $0.00 | $0 | 3,466 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −1,734 | $0.00 | $0 | 3,466 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.